ABOUT / THE PUBLISHER
About NAD Chemical
A reference-console reading of the NAD+ literature — what the publisher is, and what it is not.
What this is
NAD Chemical is a reference console for the peer-reviewed literature on NAD+ (nicotinamide adenine dinucleotide) and its precursors. We read the published studies — the precursor trials, the mechanism reviews, the brain and IV-therapy work — and lay them out plainly, with every quantitative claim cited to its source. Think of it as a developer-style reference console for one endogenous coenzyme: each finding logged, tagged by evidence strength, and linked back to the study it came from.
What this is not
There is no clinic here and no clinician on staff, and nothing on these pages is medical advice. It manufactures, sells, compounds, and distributes nothing — no NAD+, no NMN, no NR, no IV infusions, not a thing. What it logs is commentary on published science, each entry traced to source.
The word "chemical" in the name is editorial framing — the register of a fiduciary reference console reading the chemistry of a molecule, not a claim that the site is a supplier or a laboratory. NAD+ is an endogenous metabolite sold elsewhere as a dietary supplement; nothing here is for sale, and nothing here is a prescription.
How we handle the evidence
We keep three lines clear that marketing tends to blur. First, NAD+ the coenzyme is distinct from its precursors — an oral NMN or NR study is never described as "taking NAD+." Second, route matters: the well-tolerated oral-precursor trials are kept apart from the weak-evidence, unapproved IV/injectable route. Third, raising blood NAD+ is not the same as changing a clinical outcome — we report the biomarker and the endpoint separately, and we flag where a 2025 review found the human efficacy data still limited [1]. When the data stop, we say so rather than fill the gap.
Sourcing
Citations are drawn from PubMed-indexed journals, randomized clinical trials, and peer-reviewed reviews. Every figure on the site carries a numbered marker resolving to the full reference list, with DOIs and PubMed links for verification. Where a finding is preclinical or in-vitro, it is labeled as such; where it is a review rather than primary data, that is stated too.